ANG Lifesciences India (BOM:540694) Change In Payables And Accrued Expense : ₹0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Change In Payables And Accrued Expense?

ANG Lifesciences India's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was ₹0 Mil. It means ANG Lifesciences India's Accounts Payable & Accrued Expense stayed the same from Sep. 2024 to Dec. 2024 .

ANG Lifesciences India's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0 Mil. It means ANG Lifesciences India's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

ANG Lifesciences India Change In Payables And Accrued Expense Historical Data

The historical data trend for ANG Lifesciences India's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Change In Payables And Accrued Expense Chart

ANG Lifesciences India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

ANG Lifesciences India Quarterly Data
	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

ANG Lifesciences India Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

ANG Lifesciences India Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ANG Lifesciences India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001

Website

https://www.anglifesciences.com

ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. The Group has two reportable segments: Pharmaceuticals which include Manufacturing of pharmaceutical products, and Packaging and printing which include Prinitng and packaging. Key revenue is generated from Pharmaceuticals.

ANG Lifesciences India Headlines

No Headlines